Mosunetuzumab monotherapy in elderly/unfit pts with first-line diffuse large b-cell lymphoma (dlbcl): safety and efficacy remain promising with durable complete responses
Hematological Oncology(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological Oncology(2021)